IAS position paper on prevention of HIV 1 mother-to-child transmission. International Aids Society.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D003906:Developing Countries; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission*; D015497:HIV-1; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019259:Lamivudine / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D016730:Program Development; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012955:Societies, Medical; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine